OMICS International Research Article Drug Designing: Open Access D r u g D e s i g n i n g : O p e n A c c e s s ISSN: 2169-0138 Bassyouni et al., Drug Des 2017, 6:2 DOI: 10.4172/2169-0138.1000148 Volume 6 • Issue 2 • 1000148 Drug Des, an open access journal ISSN: 2169-0138 Keywords: Molecular modeling; Co-crystallized ligand; Scoring functions; Optimization; Molecular Operating Environment MOE; Drug design Introduction Te application of molecular modeling approaches for drug discovery is provided for novel therapeutic targets for drug discovery. Molecular modeling is a technique providing the energy of interaction between two molecules; this approach has several recent methods used recently in pharmaceutical applications and drug discovery [1]. It is used to allow the binding afnity of small molecule candidate drugs to their protein targets in order to improve the afnity and activity of small molecules. Molecular modeling techniques are powerful in elucidating the diferent physical, chemical and biological properties of large molecules and interactions [2,3]. In recent years, new drugs are developed from a process of trial phases in the procedure, including several computer systems developed depend on the design based on the structure of the protein and the targets are used to discover new candidates for therapeutic applications [4-9]. In addition, the physical and chemical properties of the synthesized compounds are derived from oxadiazole as antibacterial, anti- Trypanosoma cruzi and antifungal using the molecular modeling techniques that leads to more biological activity [10]. On the other hand, the quantitative structure-activity relationship (3D-QSAR) based on both the pharmacophore and the docking alignments. Tis method has been used successfully to assist in the design of new small molecule candidates and to investigate the mechanism of ligand-protein interaction [11,12]. Materials and Methods In the present study the tested compounds 1, 3, 8, 9, 10 and 12 were allowed; 3D conformations and reduction of the energy to be minimized were determined using ChemBioOfce V12 and Merifom Merck *Corresponding author: Fatma Bassyouni, Chemistry of Natural and Microbial Products Department, National Research Centre, Cairo, Egypt, Tel: 020- 01118596967; E-mail: fatma.nrc@hotmail.com Received April 06, 2017; Accepted June 07, 2017; Published June 14, 2017 Citation: Bassyouni F, El Hefnawi M, El Rashed A, Rehim MA (2017) Molecular Modeling and Biological Activities of New Potent Antimicrobial, Anti-Infammatory and Anti-Nociceptive of 5-Nitro Indoline-2-One Derivatives. Drug Des 6: 148. doi: 10.4172/2169-0138.1000148 Copyright: © 2017 Bassyouni F, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Molecular Modeling and Biological Activities of New Potent Antimicrobial, Anti-Inflammatory and Anti-Nociceptive of 5-Nitro Indoline-2-One Derivatives Fatma Bassyouni 1 *, Mahmoud El Hefnawi 2 , Ahmed El Rashed 1 and Mohamed Abdel Rehim 3 1 Department of Chemistry of Natural and Microbial Products, National Research Centre, Dokki, Cairo, Egypt 2 Informatics and Systems Department, National Research Centre, Cairo, Egypt 3 Department of Analytical Chemistry, Stockholm University, Stockholm, Sweden Abstract In recent years, molecular modeling has become an important technique for drug discovery and pharmaceutical science. The objective of this study is to determine the molecular modeling of the antibacterial, anti-infammatory and anti-nociceptive activities of a new series of pyrazoles, oxadiazoles and sugar hydrazines of 5-nitroindolin-2- one derivatives. The molecular modeling protocol was applied using the MOE (Molecular Operating Environment) software. Synthetic compounds 1, 3, 8, 9, 10 and 12 were the most active compounds, as antibacterial, anti- infammatory and anti-nociceptive activities were studied for the binding affnity of the cyclooxygenase1 (COX1), The glucocorticoid receptor (GR), the cytochrome P450 receptor of 14alfa-sterol demethylases (CYP51) and the dihydroprotease synthase receptor. Molecular modeling studies revealed that the [(methylbenzyl)-5-nitro-2- oxoindolin-3-ylideneamino-benzohydrazide derivative (3) gave a score of (-15.8587 kcal/mol), while 1,3,4-oxadiazol- 2-yl) phenylimino)-1-(methylbenzyl)-5-nitroindolin-2-one derivative (9) gave a higher score (-16.8038 kcal/mol) than fucanazole Co-crystallized gave a score of (-10.2837 kcal/mol). However, the compound (12), D-Arabinose- (methylbenzyl)-5-nitro-2-oxoindolin-(3-ylideneamino) hydrazone derivative gave a score of (-24.6577 kcal/mol) greater than the co-crystallized ligand which gave a score of (-16.6717 kcal/mol). Molecular Force Field function, with a maximum number of iterations of 500 and a minimum of 0.1 RMS gradients [13]. Te PharmMapper service was used to predict targets based on the Pharmaparget db database containing 7000 pharmacophores based on a set of 1500 drug targets [14]. Te procedure was followed using the standard protocol set on SurFlex-dock and the geometry of the result was studied using the SurFlex-dock Pose Viewer installation. Tis study aims to model the optimization of the tested compounds for more potent inhibitors using the protocol steps that was developed by the MOE operating environment sofware [15] and to reducing the minimum energy of the tested compounds in the feld of the fmmf-Hamiltonian-Force94x, followed by systematic conformational research (RMS gradient 0.01), the best 30 were stored in the database format (PDB2Oye) [16]. Active site Finder tool of MOE was used to identify and calculate active sites in the receptor molecule from the 3D atomic coordinates of the receptor. By default, all calculated sites were appeared as selected. Before the docking a database of these ligands was prepared using MOE.. Tese sites were refned with the help of the global handheld from the preliminary docking of the tested compounds,